What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 6 minute read Technology Industry News Can Cognizant (NASDAQ: CTSH) train two million people for the AI era? Inside its Synapse skilling expansion to 2030 Cognizant sets bold new Synapse target to train 2 million individuals by 2030. Explore how this move reshapes global digital skilling in the AI age. bySrinathDecember 4, 2025